[1]李 琼,李江涛,杨 帆,等.免疫抑制剂在常染色体显性遗传性多囊肾患者肾移植术后的应用[J].南方医科大学学报,2020,(04):538-543.[doi:10.12122/j.issn.1673-4254.2020.04.14]
 Application of immunosuppressants in patients with autosomal dominant polycystickidney disease after kidney transplantation[J].Journal of Southern Medical University,2020,(04):538-543.[doi:10.12122/j.issn.1673-4254.2020.04.14]
点击复制

免疫抑制剂在常染色体显性遗传性多囊肾患者肾移植术后的应用()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2020年04期
页码:
538-543
栏目:
出版日期:
2020-04-30

文章信息/Info

Title:
Application of immunosuppressants in patients with autosomal dominant polycystic kidney disease after kidney transplantation
作者:
李 琼李江涛杨 帆刘燕娜邓文锋刘如敏胡杨澄夏仁飞徐 健苗 芸
关键词:
常染色体显性遗传性多囊肾病免疫抑制剂泌尿道感染
Keywords:
autosomal dominant polycystic kidney disease immunosuppressant urinary tract infection
DOI:
10.12122/j.issn.1673-4254.2020.04.14
文献标志码:
A
摘要:
目的 探究常染色体显性遗传性多囊肾(ADPKD)患者肾移植术后免疫抑制剂合理血药浓度。方法 收集2000年3月~2018年1月首次肾移植的68例ADPKD患者和68名性别、年龄和移植日期相匹配的其他肾移植受者(对照组)的临床资料,分析两组患者人、肾存活率、术后并发症以及术后1年内不同时期免疫抑制剂浓度的差异。同时根据术后是否发生泌尿道感染将ADPKD患者分为泌尿道感染组与非泌尿道感染组,分析两组患者术后1年内不同时期免疫抑制剂浓度的差异。结果 ADPKD组与对照组患者1、5、10年移植受者存活率分别为96.6%、94.1%、90.6%和96.0%、93.9%、93.9%;ADPKD组与对照组患者肾存活率分别为95.2%、90.8%、79.0%和96.0%、87.2%、82.3%,差异无统计学意义(P>0.05)。在术后急性排斥反应、胃肠道症状、心血管事件、肺部感染以及肿瘤的发生率上的差异无统计学意义(P>0.05)。术后9月,ADPKD组比对照组的他克莫司、霉酚酸血药谷浓度更低(P<0.05);ADPKD组比对照组更容易发生泌尿道感染,且在ADPKD中泌尿道感染组较非泌尿道感染组的霉酚酸血药谷浓度要高(P<0.05)。结论 ADPKD患者移植术后长期维持需要的免疫抑制浓度可能要低于其他肾移植患者,且较高剂量的霉酚酸血药谷浓度与泌尿道感染的发生相关。
Abstract:
Objective To investigate the optimal dose range of immunosuppressants in patients with autosomal dominant polycystic kidney disease (ADPKD) after renal transplantation. Methods A cohort of 68 patients with ADPKD who received their first renal transplantation between March, 2000 and January, 2018 in our institute were retrospectively analyzed, with 68 non-ADPKD renal transplant recipients matched for gender, age and date of transplant as the control group. We analyzed the differences in patient and renal survival rates, postoperative complications and concentrations of immunosuppressive agents between the two groups at different time points within 1 year after kidney transplantation. The concentrations of the immunosuppressants were also compared between the ADPKD patients with urinary tract infections (UTI) and those without UTI after the transplantation. Results The recipients with ADPKD and the control recipients showed no significantly difference in the overall 1- , 5- , and 10- year patient survival rates (96.6% vs 96.0% , 94.1% vs 93.9% , and 90.6% vs 93.9% , respectively; P>0.05), 1-, 5-, and 10-year graft survival rates (95.2% vs 96.0%, 90.8% vs 87.2%, and 79.0% vs 82.3%, respectively; P>0.05), or the incidences of other post- transplant complications including acute rejection, gastrointestinal symptoms, cardiovascular events, pneumonia, and neoplasms (P>0.05). The plasma concentrations of both tacrolimus and mycophenolate mofetil (MPA) in ADPKD group were significantly lower than those in the control group at 9 months after operation (P<0.05). The incidence of UTI was significantly higher in ADPKD patients than in the control group (P<0.05). In patients with ADPKD, those with UTI after transplantation had a significantly higher MPA plasma concentration (P<0.05). Conclusion In patients with ADPKD after renal transplant, a higher dose of MPA is associated with a increased risk of UTI, and their plasma concentrations of immunosuppressants for long-term maintenance of immunosuppression regimen can be lower than those in other kidney transplantation recipients.

相似文献/References:

[1]杨俊,罗勇,邱小忠,等.FK506促进异体神经匀浆激活的巨噬细胞凋亡的实验研究[J].南方医科大学学报,2005,(01):66.
 YANG Jun,LUO Yong,QIU Xiao-zhong,et al.FK506 promotes apoptosis of macrophages activated by homogenate of allogenic nerve[J].Journal of Southern Medical University,2005,(04):66.
[2]相大勇,裴国献,裘宇容,等.异体手移植术后ATG治疗过程中T淋巴细胞亚群的监测(附3例报告)[J].南方医科大学学报,2004,(02):195.
 XIANG Da-yong,PEI Guo-xian,QIU Yu-rong,et al.Monitoring of T lymphocyte subset during ATG induction therapy in hand allograft with report of 3 cases[J].Journal of Southern Medical University,2004,(04):195.
[3]傅卫军,陈辉,徐建设,等.肝脏移植术后自身免疫性溶血性贫血:附3 例报告[J].南方医科大学学报,2013,(08):1240.
[4]周易,姚雷雨,于哲,等.BK多瘤病毒在肾移植受者中的感染特征[J].南方医科大学学报,2019,(01):120.[doi:10.12122/j.issn.1673-4254.2019.01.19]

更新日期/Last Update: 2020-04-30